The rs4968210GG genotype of TNFSF13 was associated with a lower percentage of CD19+APRIL+ cells in CLL patients when compared to (AA + GA) genotypes (p-value = 0.027). Here, TNFSF13 is linked to B-cell chronic lymphocytic leukemia.